{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T12:53:37Z","timestamp":1786971217345,"version":"build-2736575974"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"DOI":"10.1007\/s40618-025-02709-y","type":"journal-article","created":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T11:33:37Z","timestamp":1762947217000},"page":"131-142","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Role of MEN1 mutations on postoperative outcomes of patients with multiple endocrine neoplasia type 1-related primary hyperparathyroidism: a single center experience"],"prefix":"10.1007","volume":"49","author":[{"given":"Laura","family":"Pierotti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Pardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Sardella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone Della","family":"Valentina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Dal","family":"Lago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Piaggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Materazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Frustaci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fausto","family":"Bogazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liborio","family":"Torregrossa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Michelucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Adelaide","family":"Caligo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Marcocci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2558-9547","authenticated-orcid":false,"given":"Filomena","family":"Cetani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,12]]},"reference":[{"key":"2709_CR1","doi-asserted-by":"crossref","unstructured":"Wermer P. Genetic aspects of adenomatosis of endocrine glands. Am J Med [Internet] (1954) 16(3):363\u201371. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/0002934354903538 16 Mar 1954.","DOI":"10.1016\/0002-9343(54)90353-8"},{"key":"2709_CR2","doi-asserted-by":"crossref","unstructured":"Al-Salameh A, Cadiot G, Calender A, Goudet P, Chanson P. (2021) Clinical aspects of multiple endocrine neoplasia type 1. Nat Rev Endocrinol [Internet] 17(4):207\u201324. Available from: http:\/\/www.nature.com\/articles\/s41574-021-00468-3 9 Apr 2021.","DOI":"10.1038\/s41574-021-00468-3"},{"key":"2709_CR3","doi-asserted-by":"crossref","unstructured":"Kamilaris CDC, Stratakis CA. (2019). Multiple endocrine neoplasia type 1 (MEN1): An update and the significance of early genetic and clinical diagnosis. Vol. 10, Frontiers in Endocrinology. Frontiers Media S.A.","DOI":"10.3389\/fendo.2019.00339"},{"issue":"4","key":"2709_CR4","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1111\/j.1365-2265.2007.02934.x","volume":"67","author":"A Machens","year":"2007","unstructured":"Machens A, Schaaf L, Karges W, Frank-Raue K, Bartsch DK, Rothmund M et al (2007) Age-related penetrance of endocrine tumours in multiple endocrine neoplasia type 1 (MEN1): a multicentre study of 258 gene carriers. Clin Endocrinol (Oxf) 67(4):613\u2013622","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2709_CR5","doi-asserted-by":"crossref","unstructured":"Thakker RV, Newey PJ, Walls GV, Bilezikian J, Dralle H, Ebeling PR, et al. 2012 Clinical Practice Guidelines for Multiple Endocrine Neoplasia Type 1 (MEN1). J Clin Endocrinol Metab [Internet] 97(9):2990\u20133011. Available from: https:\/\/academic.oup.com\/jcem\/article\/97\/9\/2990\/2536740 1 Sep 2012.","DOI":"10.1210\/jc.2012-1230"},{"issue":"1","key":"2709_CR6","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/1750-1172-8-50","volume":"8","author":"BA Twigt","year":"2013","unstructured":"Twigt BA, Scholten A, Valk GD, Rinkes IHB, Vriens MR (2013) Differences between sporadic and MEN related primary hyperparathyroidism; clinical expression, preoperative workup, operative strategy and follow-up. Orphanet J Rare Dis 8(1):50","journal-title":"Orphanet J Rare Dis"},{"issue":"8","key":"2709_CR7","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1359\/jbmr.090304","volume":"24","author":"C Eller-Vainicher","year":"2009","unstructured":"Eller-Vainicher C, Chiodini I, Battista C, Viti R, Mascia ML, Massironi S et al (2009) Sporadic and MEN1-related primary hyperparathyroidism: differences in clinical expression and severity. J Bone Miner Res 24(8):1404\u20131410","journal-title":"J Bone Miner Res"},{"issue":"7","key":"2709_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11071967","volume":"11","author":"MP Yavropoulou","year":"2022","unstructured":"Yavropoulou MP, Vlachou S, Tsoli M, Fostira F, Kaltsas G, Kassi E (2022) Management and long-term follow-up of hyperparathyroidism in multiple endocrine neoplasia type 1: single center experience. J Clin Med 11(7):1967","journal-title":"J Clin Med"},{"issue":"6","key":"2709_CR9","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1097\/SLA.0b013e31811f4467","volume":"246","author":"F Tonelli","year":"2007","unstructured":"Tonelli F, Marcucci T, Fratini G, Tommasi MS, Falchetti A, Brandi ML (2007) Is total parathyroidectomy the treatment of choice for hyperparathyroidism in multiple endocrine neoplasia type 1? Ann Surg 246(6):1075\u20131082","journal-title":"Ann Surg"},{"issue":"1\u20132","key":"2709_CR10","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.mce.2013.08.002","volume":"386","author":"RV Thakker","year":"2014","unstructured":"Thakker RV (2014) Multiple endocrine neoplasia type 1 (MEN1) and type 4 (MEN4). Mol Cell Endocrinol 386(1\u20132):2\u201315","journal-title":"Mol Cell Endocrinol"},{"key":"2709_CR11","doi-asserted-by":"crossref","unstructured":"Balogh K, Pat\u00f3cs A, Hunyady L, R\u00e1cz K. (2010). Menin dynamics and functional insight: Take your partners. Mol Cell Endocrinol [Internet] 326(1\u20132):80\u20134. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303720710002169 15 Sep 2010.","DOI":"10.1016\/j.mce.2010.04.011"},{"key":"2709_CR12","doi-asserted-by":"publisher","unstructured":"Pardi E, Borsari S, Saponaro F, Bogazzi F, Urbani C, Mariotti S, et al. (2017). Mutational and large deletion study of genes implicated in hereditary forms of primary hyperparathyroidism and correlation with clinical features. Brusgaard K, editor. PLoS One [Internet] 12(10):e0186485. Available from: https:\/\/dx.plos.org\/https:\/\/doi.org\/10.1371\/journal.pone.0186485 16 Oct 2017.","DOI":"10.1371\/journal.pone.0186485"},{"issue":"1","key":"2709_CR13","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1002\/humu.21170","volume":"31","author":"JJO Turner","year":"2010","unstructured":"Turner JJO, Christie PT, Pearce SHS, Turnpenny PD, Thakker RV (2010) Diagnostic challenges due to phenocopies: lessons from Multiple Endocrine Neoplasia type1 (MEN1). Hum Mutat 31(1):1089\u20131101","journal-title":"Hum Mutat"},{"issue":"2","key":"2709_CR14","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s12020-019-01932-x","volume":"65","author":"A K\u00f6vesdi","year":"2019","unstructured":"K\u00f6vesdi A, T\u00f3th M, Butz H, Sz\u00fccs N, S\u00e1rm\u00e1n B, Pusztai P et al (2019) True MEN1 or phenocopy? Evidence for geno-phenotypic correlations in MEN1 syndrome. Endocrine 65(2):451\u2013459","journal-title":"Endocrine"},{"issue":"1","key":"2709_CR15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12916-016-0708-1","volume":"14","author":"JM de Laat","year":"2016","unstructured":"de Laat JM, van der Luijt RB, Pieterman CRC, Oostveen MP, Hermus AR, Dekkers OM et al (2016) MEN1 redefined, a clinical comparison of mutation-positive and mutation-negative patients. BMC Med 14(1):1\u20139","journal-title":"BMC Med"},{"issue":"4","key":"2709_CR16","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1046\/j.1365-2265.2000.00966.x","volume":"52","author":"N Hai","year":"2000","unstructured":"Hai N, Aoki N, Shimatsu A, Mori T, Kosugi S (2000) Clinical features of multiple endocrine neoplasia type 1 (MEN1) phenocopy without germline MEN1 gene mutations: analysis of 20 Japanese sporadic cases with MEN1. Clin Endocrinol (Oxf) 52(4):509\u2013518","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2709_CR17","doi-asserted-by":"crossref","unstructured":"Worthy CC, Tora R, Uttarkar CN, Welch JM, Bliss L, Cochran C, et al. (2025). Genotype-phenotype correlation in multiple endocrine neoplasia type 1. JCI Insight [Internet] 10(6). Available from: https:\/\/insight.jci.org\/articles\/view\/176993 24 Mar 2025","DOI":"10.1172\/jci.insight.176993"},{"issue":"9","key":"2709_CR18","doi-asserted-by":"publisher","first-page":"2990","DOI":"10.1210\/jc.2012-1230","volume":"97","author":"RV Thakker","year":"2012","unstructured":"Thakker RV, Newey PJ, Walls GV, Bilezikian J, Dralle H, Ebeling PR et al (2012) Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1). J Clin Endocrinol Metab 97(9):2990\u20133011","journal-title":"J Clin Endocrinol Metab"},{"key":"2709_CR19","doi-asserted-by":"crossref","unstructured":"Montenegro FL de M, Brescia MDG, Louren\u00e7o DM, Arap SS, d\u2019Alessandro AF, de Britto e Silva Filho G, et al. (2019). Could the Less-Than Subtotal Parathyroidectomy Be an Option for Treating Young Patients With Multiple Endocrine Neoplasia Type 1-Related Hyperparathyroidism? Front Endocrinol (Lausanne) 10 7 Mar 2019.","DOI":"10.3389\/fendo.2019.00123"},{"issue":"1","key":"2709_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-67424-5","volume":"10","author":"HR Choi","year":"2020","unstructured":"Choi HR, Choi SH, Choi SM, Kim JK, Lee CR, Kang SW et al (2020) Benefit of diverse surgical approach on short-term outcomes of MEN1-related hyperparathyroidism. Sci Rep 10(1):10634","journal-title":"Sci Rep"},{"key":"2709_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(25)00119-6","author":"ML Brandi","year":"2025","unstructured":"Brandi ML, Pieterman CRC, English KA, Lines KE, Shariq OA, Marini F et al (2025) Multiple endocrine neoplasia type 1 (MEN1): recommendations and guidelines for best practice. Lancet Diabetes Endocrinol. https:\/\/doi.org\/10.1016\/S2213-8587(25)00119-6","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"11","key":"2709_CR22","doi-asserted-by":"publisher","first-page":"2666","DOI":"10.1007\/s00268-022-06633-7","volume":"46","author":"D Bouriez","year":"2022","unstructured":"Bouriez D, Gronnier C, Haissaguerre M, Tabarin A, Najah H (2022) Less than subtotal parathyroidectomy for multiple endocrine neoplasia type 1 primary hyperparathyroidism: a systematic review and meta-analysis. World J Surg 46(11):2666\u20132675","journal-title":"World J Surg"},{"issue":"4","key":"2709_CR23","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1111\/cen.14727","volume":"97","author":"CRC Pieterman","year":"2022","unstructured":"Pieterman CRC, Valk GD (2022) Update on the clinical management of multiple endocrine neoplasia type 1. Clin Endocrinol (Oxf) 97(4):409\u2013423","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"2709_CR24","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.surg.2020.08.021","volume":"169","author":"C Nastos","year":"2021","unstructured":"Nastos C, Papaconstantinou D, Kofopoulos-Lymperis E, Peppa M, Pikoulis A, Lykoudis P et al (2021) Optimal extent of initial parathyroid resection in patients with multiple endocrine neoplasia syndrome type 1: a meta-analysis. Surgery 169(2):302\u2013310","journal-title":"Surgery"},{"issue":"6","key":"2709_CR25","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1016\/j.surg.2014.08.006","volume":"156","author":"TC Lairmore","year":"2014","unstructured":"Lairmore TC, Govednik CM, Quinn CE, Sigmond BR, Lee CY, Jupiter DC (2014) A randomized, prospective trial of operative treatments for hyperparathyroidism in patients with multiple endocrine neoplasia type 1. Surgery 156(6):1326\u20131335","journal-title":"Surgery"},{"key":"2709_CR26","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1097\/SLA.0b013e31824c5145","volume":"255","author":"CRC Pieterman","year":"2012","unstructured":"Pieterman CRC, Van Hulsteijn LT, Den Heijer M, Van Der Luijt RB, Bonenkamp JJ, Hermus ARMM et al (2012) Primary hyperparathyroidism in MEN1 patients: a cohort study with longterm follow-up on preferred surgical procedure and the relation with genotype. Ann Surg 255:1171\u20131178","journal-title":"Ann Surg"},{"issue":"1","key":"2709_CR27","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/cen.14112","volume":"92","author":"J Manoharan","year":"2020","unstructured":"Manoharan J, Albers MB, Bollmann C, Maurer E, Mintziras I, W\u00e4chter S et al (2020) Single gland excision for MEN1-associated primary hyperparathyroidism. Clin Endocrinol (Oxf) 92(1):63\u201370","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"10","key":"2709_CR28","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1530\/EC-19-0321","volume":"8","author":"C Lamas","year":"2019","unstructured":"Lamas C, Navarro E, Caster\u00e1s A, Portillo P, Alc\u00e1zar V, Calatayud M et al (2019) MEN1-associated primary hyperparathyroidism in the Spanish registry: clinical characterictics and surgical outcomes. Endocr Connect 8(10):1416\u20131424","journal-title":"Endocr Connect"},{"issue":"3","key":"2709_CR29","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1097\/SLA.0b013e31815efda5","volume":"247","author":"JA Norton","year":"2008","unstructured":"Norton JA, Venzon DJ, Berna MJ, Alexander HR, Fraker DL, Libutti SK et al (2008) Prospective study of surgery for primary hyperparathyroidism (HPT) in multiple endocrine neoplasia-type 1 and Zollinger-Ellison syndrome long-term outcome of a more virulent form of HPT. Ann Surg 247(3):501\u2013510","journal-title":"Ann Surg"},{"issue":"4","key":"2709_CR30","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1001\/archsurg.140.4.374","volume":"140","author":"LA Lambert","year":"2005","unstructured":"Lambert LA (2005) Surgical treatment of hyperparathyroidism in patients with multiple endocrine neoplasia type 1. Arch Surg 140(4):374","journal-title":"Arch Surg"},{"issue":"9","key":"2709_CR31","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1007\/s00268-011-1068-9","volume":"35","author":"JMJ Schreinemakers","year":"2011","unstructured":"Schreinemakers JMJ, Pieterman CRC, Scholten A, Vriens MR, Valk GD, Borel Rinkes IHM (2011) The optimal surgical treatment for primary hyperparathyroidism in MEN1 patients: a systematic review. World J Surg 35(9):1993\u20132005","journal-title":"World J Surg"},{"issue":"3","key":"2709_CR32","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s00268-015-3297-9","volume":"40","author":"E Fyrsten","year":"2016","unstructured":"Fyrsten E, Norl\u00e9n O, Hessman O, St\u00e5lberg P, Hellman P (2016) Long-term surveillance of treated hyperparathyroidism for multiple endocrine neoplasia type 1: recurrence or hypoparathyroidism? World J Surg 40(3):615\u2013621","journal-title":"World J Surg"},{"issue":"7","key":"2709_CR33","doi-asserted-by":"publisher","first-page":"3045","DOI":"10.1007\/s00423-022-02660-z","volume":"407","author":"K Van Den Heede","year":"2022","unstructured":"Van Den Heede K, Bonheure A, Brusselaers N, Van Slycke S (2022) Long-term outcome of surgical techniques for sporadic primary hyperparathyroidism in a tertiary referral center in Belgium. Langenbecks Arch Surg 407(7):3045\u20133055","journal-title":"Langenbecks Arch Surg"},{"issue":"2","key":"2709_CR34","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1097\/SLA.0000000000005980","volume":"279","author":"N Santucci","year":"2024","unstructured":"Santucci N, Ksiazek E, Pattou F, Baud G, Miralli\u00e9 E, Frey S et al (2024) Recurrence after surgery for primary hyperparathyroidism in 517 patients with multiple endocrine neoplasia type 1: an Association Francophone de Chirurgie Endocrinienne and Groupe d\u2019\u00e9tude des Tumeurs Endocrines study. Ann Surg 279(2):340\u2013345","journal-title":"Ann Surg"},{"key":"2709_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1414896","author":"E Dinoi","year":"2024","unstructured":"Dinoi E, Prete A, Sardella C, Pierotti L, Della Valentina S, Dal Lago A (2024) The challenge of the differential diagnosis between brown tumors and metastases in parathyroid carcinoma: a case report. Front Endocrinol (Lausanne). https:\/\/doi.org\/10.3389\/fendo.2024.1414896","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"2709_CR36","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/humu.20605","volume":"29","author":"MC Lemos","year":"2008","unstructured":"Lemos MC, Thakker RV (2008) Multiple endocrine neoplasia type 1 (MEN1): analysis of 1336 mutations reported in the first decade following identification of the gene. Hum Mutat 29(1):22\u201332","journal-title":"Hum Mutat"},{"issue":"9","key":"2709_CR37","doi-asserted-by":"publisher","first-page":"3389","DOI":"10.1210\/jc.2007-0476","volume":"92","author":"E Tham","year":"2007","unstructured":"Tham E, Grandell U, Lindgren E, Toss G, Skogseid B, Nordenskj\u00f6ld M (2007) Clinical testing for mutations in the MEN1 gene in Sweden: a report on 200 unrelated cases. J Clin Endocrinol Metab 92(9):3389\u20133395","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2709_CR38","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1046\/j.1365-2265.2002.01502.x","volume":"56","author":"F Cetani","year":"2002","unstructured":"Cetani F, Pardi E, Giovannetti A, Vignali E, Borsari S, Golia F et al (2002) Genetic analysis of the MEN1 gene and HPRT2 locus in two Italian kindreds with familial isolated hyperparathyroidism. Clin Endocrinol (Oxf) 56(4):457\u2013464","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2709_CR39","first-page":"14","volume":"7","author":"L Pierotti","year":"2023","unstructured":"Pierotti L, Pardi E, Dinoi E, Piaggi P, Borsari S, Della Valentina S et al (2023) Cutaneous lesions and other non-endocrine manifestations of Multiple Endocrine Neoplasia type 1 syndrome. Front Endocrinol (Lausanne) 7:14","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2709_CR40","unstructured":"Bilezikian JP, Khan AA, Silverberg SJ, El\u2010Hajj Fuleihan G, Marcocci C, Minisola S, et al. (2022). Evaluation and Management of Primary Hyperparathyroidism: Summary Statement and Guidelines from the Fifth International Workshop. Journal of Bone and Mineral Research 19 Aug 2022."},{"issue":"12","key":"2709_CR41","doi-asserted-by":"publisher","first-page":"2568","DOI":"10.1002\/jbmr.4691","volume":"37","author":"AA Khan","year":"2020","unstructured":"Khan AA, Bilezikian JP, Brandi ML, Clarke BL, Gittoes NJ, Pasieka JL (2020) Evaluation and management of hypoparathyroidism summary statement and guidelines from the second international workshop. J Bone Miner Res 37(12):2568\u20132585","journal-title":"J Bone Miner Res"},{"key":"2709_CR42","doi-asserted-by":"crossref","unstructured":"Uludag M. (2023). Persistent and Recurrent Primary Hyperparathyroidism: Etiological Factors and Preoperative Evaluation. SiSli Etfal Hastanesi Tip Bulteni \/ The Medical Bulletin of Sisli Hospital","DOI":"10.14744\/SEMB.2023.39260"},{"issue":"1","key":"2709_CR43","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.surg.2021.06.035","volume":"171","author":"AS Shirali","year":"2022","unstructured":"Shirali AS, Wu SY, Chiang YJ, Graham PH, Grubbs EG, Lee JE et al (2022) Recurrence after successful parathyroidectomy\u2014who should we worry about? Surgery 171(1):40\u201346","journal-title":"Surgery"},{"issue":"1","key":"2709_CR44","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.surg.2019.05.076","volume":"167","author":"R Mallick","year":"2020","unstructured":"Mallick R, Nicholson KJ, Yip L, Carty SE, McCoy KL (2020) Factors associated with late recurrence after parathyroidectomy for primary hyperparathyroidism. Surgery 167(1):160\u2013165","journal-title":"Surgery"},{"key":"2709_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2020.04.067","author":"CRC Pieterman","year":"2021","unstructured":"Pieterman CRC, Hyde SM, Wu SY, Landry JP, Chiang YJ, Christakis I et al (2021) Understanding the clinical course of genotype-negative MEN1 patients can inform management strategies. Surgery. https:\/\/doi.org\/10.1016\/j.surg.2020.04.067","journal-title":"Surgery"},{"issue":"2","key":"2709_CR46","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s12020-019-01932-x","volume":"65","author":"A K\u00f6vesdi","year":"2019","unstructured":"K\u00f6vesdi A, T\u00f3th M, Butz H, Sz\u00fccs N, S\u00e1rm\u00e1n B, Pusztai P et al (2019) True MEN1 or phenocopy? Evidence for geno-phenotypic correlations in MEN1 syndrome. Endocrine 65(2):451\u20139. https:\/\/doi.org\/10.1007\/s12020-019-01932-x","journal-title":"Endocrine"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-025-02709-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-025-02709-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-025-02709-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T19:02:48Z","timestamp":1769540568000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-025-02709-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,12]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["2709"],"URL":"https:\/\/doi.org\/10.1007\/s40618-025-02709-y","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,12]]},"assertion":[{"value":"7 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study has been approved by the appropriate institutional and\/or national research ethics committee and has been performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The last and Corresponding Author of this paper is an Associate Editor of JENI. All other authors declare that they have no conflicts of interest regarding material presented in this review.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}